The Patent Finder

Imtm GmbH

Also on record
Records under this name other than patents Imtm GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Imtm GmbH

PatentTitleStatus Expires Confidence
US 8,470,855Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseases
Lapsed on the fee record
Ended Jun 25, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 25, 2017From the USPTO record
US 8,263,636Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
Formerly held
Lapsed on the fee record
Ended Sep 11, 2016 · From the USPTO record
Lapsed on the fee recordEnded Sep 11, 2016From the USPTO record
US 7,291,599Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases
Lapsed on the fee record
Ended Nov 6, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 6, 2015From the USPTO record
US 7,229,969Combinations of enzyme inhibitors and the use thereof
Lapsed on the fee record
Ended Jun 12, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2015From the USPTO record
US 7,858,655Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
Formerly held
Lapsed on the fee record
Ended Dec 28, 2014 · From the USPTO record
Lapsed on the fee recordEnded Dec 28, 2014From the USPTO record
US 7,683,034Use of enzyme inhibitors of aminopeptidase N and/or dipeptidylpeptidase IV
Lapsed on the fee record
Ended Mar 23, 2014 · From the USPTO record
Lapsed on the fee recordEnded Mar 23, 2014From the USPTO record
US 7,485,626Combinations of enzyme inhibitor-containing preparations and the use thereof
Lapsed on the fee record
Ended Feb 3, 2013 · From the USPTO record
Lapsed on the fee recordEnded Feb 3, 2013From the USPTO record
US 7,429,614Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus
Lapsed on the fee record
Ended Sep 30, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 30, 2012From the USPTO record
US 7,425,532Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
Lapsed on the fee record
Ended Sep 16, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 16, 2012From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited